提高美国特应性皮炎流行病学研究的质量——对疾病定义和国家调查中相关内容的系统回顾。

IF 5.7
Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson
{"title":"提高美国特应性皮炎流行病学研究的质量——对疾病定义和国家调查中相关内容的系统回顾。","authors":"Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson","doi":"10.1016/j.jid.2025.07.025","DOIUrl":null,"url":null,"abstract":"<p><p>Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.</p>","PeriodicalId":94239,"journal":{"name":"The Journal of investigative dermatology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving the Quality of Atopic Dermatitis Epidemiologic Research in the United States: A Systematic Review of Disease Definitions and Related Content in National Surveys.\",\"authors\":\"Sarah L Becker, Gina N Bash, Wendy Smith Begolka, Tenesha Wallace-Hood, Junko Takeshita, Aaron M Drucker, Jonathan Silverberg, Lawrence F Eichenfield, Katrina Abuabara, Bryan Dosono, Andrew Hamilton, Robyn Okereke, Eric Simpson\",\"doi\":\"10.1016/j.jid.2025.07.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.</p>\",\"PeriodicalId\":94239,\"journal\":{\"name\":\"The Journal of investigative dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-08-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of investigative dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jid.2025.07.025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of investigative dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jid.2025.07.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

特应性皮炎的流行病学研究对于提高我们对疾病负担的理解和识别许多特应性和非特应性合并症至关重要。尽管广泛使用,但特应性皮炎病例定义和相关内容在基于人群的调查中尚未得到全面评估。为了描述包括特应性皮炎或湿疹在内的美国基于人群的健康相关调查的状况,我们对Ovid MEDLINE进行了系统回顾,检索了从数据库建立到2025年3月26日美国基于人群的特应性皮炎调查。在筛选的916篇文章中,纳入24篇文章进行分析,其中包括11项独立调查。大多数调查依赖于医生诊断特应性皮炎的自我报告或儿童哮喘和过敏国际研究(ISAAC)标准,包括未经验证的ISAAC标准的修改版本。全国性调查提供了最大的样本,通常每年重复一次,但近年来一些全国性调查没有包括特应性皮炎的问题。国家调查没有使用标准化定义来确定特应性皮炎,也没有充分捕捉特应性皮炎负担的关键方面。未来以人口为基础的调查应旨在填补这些重要空白。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Improving the Quality of Atopic Dermatitis Epidemiologic Research in the United States: A Systematic Review of Disease Definitions and Related Content in National Surveys.

Epidemiologic studies of atopic dermatitis (AD) are critical to improve our understanding of the disease burden and to identify numerous atopic and nonatopic comorbidities. Despite their widespread use, the definitions and related contents of AD in population-based surveys have not been comprehensively evaluated. To characterize the state of population-based health-related surveys in the United States that include AD or eczema, we conducted a systematic review of Ovid MEDLINE to study AD in the United States from database inception through March 26, 2025. Of the 916 articles screened, 24 were included in the analysis, which included 11 independent surveys. Most surveys rely on self-reporting of physician diagnosis of AD or the International Study of Asthma and Allergies in Childhood criteria, including a modified version of the International Study of Asthma and Allergies in Childhood criteria, which has not been validated. National surveys yield the largest sample and are typically repeated annually; however, some national surveys have not included questions on AD in recent years. National surveys do not use standardized definitions to identify AD and do not adequately capture the key aspects of AD burden. Therefore, future population-based surveys should address these issues.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信